Biomarin Pharmaceutical (BMRN) Return on Capital Employed Growth (5y) (2015 - 2026)
Biomarin Pharmaceutical (BMRN) Return on Capital Employed Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,011.97 Bn | 67,011.68 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.88 Bn | 467.08 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.20 Bn | 114.96 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.17 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.85 Bn | 50.67 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Biomarin Pharmaceutical | 11.71 Bn | 9.49 Bn | 571.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 660.00 |
| Dec 31, 2025 | 677.00 |
| Sep 30, 2025 | 916.00 |
| Jun 30, 2025 | 1,033.00 |
| Mar 31, 2025 | 812.00 |
| Dec 31, 2024 | 1,039.00 |
| Sep 30, 2024 | 886.00 |
| Jun 30, 2024 | 827.00 |
| Mar 31, 2024 | 706.00 |
| Dec 31, 2023 | 636.00 |
| Sep 30, 2023 | 336.00 |
| Jun 30, 2023 | 257.00 |
| Mar 31, 2023 | 249.00 |
| Dec 31, 2022 | 320.00 |
| Sep 30, 2022 | 609.00 |
| Jun 30, 2022 | 681.00 |
| Mar 31, 2022 | 2,094.00 |
| Dec 31, 2021 | 2,148.00 |
| Sep 30, 2021 | 1,858.00 |
| Jun 30, 2021 | 1,975.00 |